Exploratory Phase II Multicenter, Open-Label, Clincal Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects

Jeng, Bennie H., Hamrah, Pedram. Kirshner, Ziv Z., Mendez, Benjamin C., Wessel, Howard C., Brown, Larry R., Steed, David L. (January 2022).

Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects. Translational Vision Science & Technology January 2022 Volume 11 No 1 Article 8.

Full publication here.